Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 3 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

2Total
Not Applicable (2)

Trial Status

Recruiting3

Clinical Trials (3)

Showing 3 of 3 trials
NCT06804525RecruitingPrimary

LHC-CIDI-5 in Hong Kong

NCT07258914Not ApplicableRecruiting

Feasibility and Efficacy of rTMS in Depression in Patients With Autism Spectrum Disorder (ASD)

NCT07031817Not ApplicableRecruiting

Validation of a Composite Medical Device Using a Blood Biomarker-based Algorithm and MDQ for the Diagnosis of Bipolar Disorder

Showing all 3 trials

Research Network

Activity Timeline